Kaiser Permanente

Kaiser Permanente is a nonprofit healthcare organization that offers a variety of services, including preventive care, emergency care, hospital services, and pharmacy offerings. Founded in 1945 and headquartered in Oakland, California, it serves members across multiple states, including California, Colorado, Georgia, Hawaii, Ohio, Oregon, Washington, and the District of Columbia. The organization is recognized as a leader in the healthcare sector, focusing on comprehensive care that encompasses well-baby and prenatal services, immunizations, and diagnostic screenings. Additionally, Kaiser Permanente Ventures, its venture capital arm established in 1997, invests in innovative healthcare companies in the United States, targeting sectors such as medical devices, therapeutics, health care services, and health care information technology. The venture arm typically invests between $0.5 million and $12 million in companies with significant market potential and prefers to collaborate with other investors in the healthcare space.

Amy Belt

Managing Director

Samuel E. Brasch

Senior VP & Senior MD

Olivia Capra

Senior Associate

Christopher M. Grant

Chief Operating Officer & Executive Vice President

Nemariam Mesfin

Director of Finance

Liz Rockett

MD

Chris Stenzel

SVP, Business Development and Innovation

Past deals in Health Care

Incredible Health

Series B in 2022
Incredible Health, Inc. is a San Francisco-based company that offers an online recruitment platform designed to assist healthcare providers in hiring full-time clinical staff efficiently. The platform enables hospitals and health systems to find high-quality clinicians in less than 30 days, streamlining the staffing process. Unlike traditional job searches, candidates do not apply to employers; instead, employers seek out candidates through an intuitive web application. Incredible Health also provides a mobile application that enhances the user experience. The company, originally known as Lift League, Inc., was incorporated in 2015 and has since focused on solving staffing challenges within the healthcare industry by allowing users to filter job searches, receive alerts, and access career advice.

IntelyCare

Series C in 2022
IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

Big Health

Series C in 2022
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

DexCare

Series B in 2022
DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Medically Home

Venture Round in 2022
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

OM1

Series D in 2021
OM1 (formerly Better Outcomes) is a digital health company focused on solving the problem of determining and understanding the true results of healthcare. We believe that a value-based healthcare system requires a much more complete view of patient outcomes than has been available until now. We leverage a state-of-the-art technology platform, a world-class team of scientists, clinical experts and software engineers, and a committed network of organizations to create a new standard for health outcomes information.

Protenus

Series D in 2021
The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting compliance teams to policy violations, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

Medically Home

Corporate Round in 2021
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.

Groups Recover Together

Series C in 2021
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Vesta Healthcare

Venture Round in 2021
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

DexCare

Series A in 2021
DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Evidation Health

Series E in 2021
Evidation Health is a provider of a health data analytics platform designed to collect and analyze continuous behavior data and healthcare information so as to create better health outcomes. Its platform turns raw, high-frequency everyday behavior data from sensors, devices, speech, video, and other sources into new knowledge about health and disease, that enable individuals and innovative companies to understand and influence the everyday behaviors. It was founded in 2012 and is headquartered in San Mateo, California.

K Health

Series E in 2021
K Health, Inc. develops and provides a health application that provides personalized and data-driven information about their symptoms and health. The company was formerly known as Kang Health, Inc. and changed its name to K Health, Inc. in November 2018. K Health, Inc. was incorporated in 2016 and is based in New York, New York with an additional office in Israel.

Ginger

Series D in 2020
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.

Genome Medical

Series B in 2020
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Cedar

Series C in 2020
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and is headquartered in New York, New York.

Big Health

Series B in 2020
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

IntelyCare

Series B in 2020
IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

Vesta Healthcare

Series A in 2020
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Ginger

Series C in 2019
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.

Protenus

Series C in 2019
The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting compliance teams to policy violations, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

Omada Health

Series D in 2019
Omada Health, Inc. is a digital healthcare company that develops online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, the company collaborates with employers and health plans to identify individuals at risk for preventable chronic conditions such as prediabetes, diabetes, hypertension, and heart disease. Omada's programs are personalized to address the evolving needs of participants, offering support in areas like diabetes prevention, type 2 diabetes management, and behavioral health. The company integrates professional health coaching, connected health devices, real-time data, and personalized feedback to achieve clinically significant outcomes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program by the Centers for Disease Control and Prevention (CDC).

Health Catalyst

Series F in 2019
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Health Catalyst

Debt Financing in 2019
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Vesta Healthcare

Series A in 2018
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Multisensor Diagnostics

Seed Round in 2018
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.

CareAcademy

Seed Round in 2018
CareAcademy operates an online training platform tailored for senior home care agencies and caregivers. Founded in 2013 by Helen Adeosun, the company provides evidence-based classes that help direct care workers enhance their skills and improve the quality of care they deliver to older adults. The platform offers a variety of courses covering essential topics such as infection control, nutrition, dementia care, and fall prevention, enabling caregivers to meet licensure requirements across all 50 states. CareAcademy has certified over 40,000 caregivers nationwide, emphasizing the importance of high-touch coaching and exceptional customer service. The training programs not only equip caregivers with the necessary knowledge and skills but also offer peace of mind to employers, ensuring that their teams are well-prepared to support seniors in living independently and safely at home.

Protenus

Series B in 2018
The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting compliance teams to policy violations, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

Genome Medical

Series A in 2018
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Collective Medical

Series A in 2017
Collective Medical Technologies, Inc. is a health care technology company that specializes in a real-time collaboration software platform designed to enhance patient care. Founded in 2005 and based in Cottonwood Heights, Utah, the platform connects a patient's entire care team, including hospitals, primary and secondary clinics, health plans, and community organizations, facilitating the sharing of vital information. Collective Medical's system-agnostic platform is utilized by a nationwide network of health plans and providers to identify at-risk patients and encourage actionable collaboration among care teams. The platform aims to improve patient outcomes by reducing unnecessary emergency department visits and hospital readmissions, utilizing real-time data, risk analytics, and shared care guidelines to inform provider decision-making. As of December 30, 2020, Collective Medical operates as a subsidiary of PointClickCare Corp.

Protenus

Series A in 2017
The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting compliance teams to policy violations, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

Big Health

Series B in 2016
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

CareGuardian

Series B in 2016
CareGuardian, founded in 2014, is dedicated to enhancing the visibility, recognition, and empowerment of caregivers, both professional and family. The company aims to deliver exceptional care and support for older adults by reimagining caregiver training and fostering connections among caregivers. CareGuardian recognizes the critical role that family caregivers play in ensuring the safety and well-being of older adults, and it extends its support to them as well. The organization operates in various regions, focusing on creating a network that promotes quality care and meaningful interactions for those involved in caregiving.

Group Health Cooperative

Acquisition in 2015
Group Health Cooperative is a member-governed, non-profit healthcare organization that coordinates care and coverage. The organization offers health plans for individuals and families; state and federal employees; and employers such as small and large groups including employer-sponsored group plans. It also provides various specialty care services at its medical centers in contracted hospitals; and healthcare, pharmacy, and drug formulary services. In addition, Group Health Cooperative conducts non-proprietary public-interest research on preventing, diagnosing, and treating major health problems in the areas of aging and geriatrics, health services and economics, alternative approaches to healing, healthy communities, behavior change, medication use and patient safety, biostatistics, mental health, cancer, obesity, cardiovascular health, preventive medicine, child and adolescent health, vaccines and infectious diseases, chronic illness management, women’s health, and health informatics. Group Health Cooperative was founded in January 1947 and is based in Seattle, Washington with administrative offices in Tukwila, Bellingham, Spokane, Tacoma, and Kennewick, Washington.

Health Catalyst

Series D in 2015
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Ginger

Series B in 2014
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.

Omada Health

Series B in 2014
Omada Health, Inc. is a digital healthcare company that develops online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, the company collaborates with employers and health plans to identify individuals at risk for preventable chronic conditions such as prediabetes, diabetes, hypertension, and heart disease. Omada's programs are personalized to address the evolving needs of participants, offering support in areas like diabetes prevention, type 2 diabetes management, and behavioral health. The company integrates professional health coaching, connected health devices, real-time data, and personalized feedback to achieve clinically significant outcomes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program by the Centers for Disease Control and Prevention (CDC).

Health Catalyst

Series C in 2014
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

iRhythm Technologies

Series D in 2013
iRhythm Technologies, Inc. is a digital healthcare company focused on improving the diagnosis and monitoring of cardiac arrhythmias in patients. Headquartered in San Francisco, the company provides innovative ambulatory electrocardiogram (ECG) monitoring solutions, primarily through its flagship product, the Zio service. This service utilizes a lightweight, wire-free, patch-based biosensor that patients can wear for up to 14 days, allowing for continuous heart monitoring. The Zio system integrates cloud-based data analytics and machine-learning capabilities to transform extensive heartbeat data into actionable clinical insights. By streamlining the diagnostic process, iRhythm aims to enhance patient health outcomes and reduce unnecessary healthcare expenses. Additionally, the company collaborates with Verily Life Sciences to develop advanced atrial fibrillation screening and monitoring products. Established in 2006, iRhythm continues to lead in the digital healthcare space by redefining cardiac arrhythmia diagnosis.

Health Catalyst

Series B in 2013
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

iRhythm Technologies

Private Equity Round in 2012
iRhythm Technologies, Inc. is a digital healthcare company focused on improving the diagnosis and monitoring of cardiac arrhythmias in patients. Headquartered in San Francisco, the company provides innovative ambulatory electrocardiogram (ECG) monitoring solutions, primarily through its flagship product, the Zio service. This service utilizes a lightweight, wire-free, patch-based biosensor that patients can wear for up to 14 days, allowing for continuous heart monitoring. The Zio system integrates cloud-based data analytics and machine-learning capabilities to transform extensive heartbeat data into actionable clinical insights. By streamlining the diagnostic process, iRhythm aims to enhance patient health outcomes and reduce unnecessary healthcare expenses. Additionally, the company collaborates with Verily Life Sciences to develop advanced atrial fibrillation screening and monitoring products. Established in 2006, iRhythm continues to lead in the digital healthcare space by redefining cardiac arrhythmia diagnosis.

Hemosphere

Series A in 2010
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.

Silverlink Communications

Series D in 2009
Silverlink Communications is a healthcare IT company that develops solutions for patient communications and engagement. The company provides communications services for managed care, pharmacy, population health, Medicare and Medicaid, multi-channel services, and interactive voice services.

CHF Solutions

Venture Round in 2005
CHF Solutions manufactures innovative medical devices for cardiac care. Its mission is to provide medical practitioners with practical solutions that enable the treatment of patients with unmet clinical needs. CHF Solutions was founded in 1998 and is based in Brooklyn Park, Minnesota.

Proteus Digital Health

Series B in 2004
Proteus Digital Health® is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved.

The Center from Health Promotion

Venture Round in 2003
The Center for Health Promotion Inc. delivers tobacco cessation and weight management services to customers nationwide. As an operating unit of Group Health Cooperative (Seattle) for almost 20 years, CHP developed the telephone-based Free & Clear program and established itself a national leader in tobacco cessation. Today CHP continues to deliver tobacco cessation services through health plans, businesses and labor organizations around the country. CHP also provides phone-based tobacco cessation services to residents of Georgia, Maine, Minnesota, Oklahoma, Oregon, Utah, Washington and Wisconsin through contracts with state agencies or coalitions. The company is actively engaged in research trials with major research centers including The Stanford Research Institute in Menlo Park, Calif., the Center for Health Research in Portland, Ore., and the Fred Hutchison Cancer Research Center and Group Health's Center for Health Studies, both in Seattle. This active research is undertaken to help improve CHP's services to smokers and increase scientific understanding of this key health issue.